Science Explorer Back to mapMap
Discussion
Researcher · Teva Pharmaceuticals (Israel) · Israel

Eli Eyal

Eli Eyal publishes mostly in Neurology, Epidemiology and Pharmacology, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Parkinson's Disease and Spinal Disorders.

OpenAlex
World rank
#1,289,096
of 7,710,434 ranked researchers
Rank in Israel
#8,952
of 38,292
Works
29
Citations
1.2k
Citations per work
41.9
h-index
16
i10-index 18Top 34% in Neurology (Medicine)
Eli Eyal

What does Eli Eyal research?

Eli Eyal's work is mostly in Medicine (47%), Neuroscience (5%), Immunology and Microbiology (4%).

Health Sciences: 14 works · 46.8% of their workMedicine: 14 works · 46.8% of their workNeurology: 10 works · 35.1% of their workEpidemiology: 2 works · 6.5% of their workPharmacology: 2 works · 5.2% of their workEverything else: 12 works · 40.2% of their workLife Sciences: 4 works · 13.0% of their workNeuroscience: 2 works · 5.2% of their workCellular and Molecular Neuroscience: 2 works · 5.2% of their workImmunology and Microbiology: 1 works · 3.9% of their workImmunology: 1 works · 3.9% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 3.9% of their workToxicology: 1 works · 3.9% of their workTHEIR WORKEli Eyal29works
Life Sciences13%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1446.8%
  2. Everything else1240.2%
    1. Neuroscience25.2%
    2. Immunology and Microbiology13.9%
    3. Pharmacology, Toxicology and Pharmaceutics13.9%
  1. 1Neurology35% of their works
  2. 2Epidemiology6% of their works
  3. 3Pharmacology5% of their works
  4. 4Cellular and Molecular Neuroscience5% of their works
  5. 5Immunology4% of their works
  6. 6Toxicology4% of their works

Research topics

Which keywords describe Eli Eyal's research?

The keywords of their largest research topics: Parkinson's Disease, Deep Brain Stimulation, Neurological Disorders, a-Synuclein, Basal Ganglia, Neurodegeneration, Subthalamic Nucleus and Camptocormia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Parkinson's Disease263 topics
  2. Deep Brain Stimulation162 topics
  3. Neurological Disorders162 topics
  4. Basal Ganglia101 topic
  5. Neurodegeneration101 topic
  6. Subthalamic Nucleus101 topic
  7. a-Synuclein101 topic
  8. Camptocormia61 topic
  9. Dropped Head Syndrome61 topic
  10. Drug Analysis31 topic
  11. Forensic Toxicology31 topic
  12. Acetylcholinesterase21 topic
  13. Cholinesterase Inhibitors21 topic
  14. Filaggrin21 topic
  15. Mesenchymal Stem Cells21 topic
  16. Multipotent21 topic
  17. Obesity21 topic
  18. Pharmacotherapy21 topic
  19. Skin Microbiome21 topic

Where does Eli Eyal work?

Eli Eyal's main affiliation in the publication record is Teva Pharmaceuticals (Israel), Israel.

How many publications and citations does Eli Eyal have?

OpenAlex counts 29 works and 1,214 citations for Eli Eyal, an h-index of 16, ranking #1,289,096 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Eli Eyal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.